More...Snapshot
Erlotinib Hydrochloride is an anticancer drug from protein kinase inhibitors pharmacological group. This medication is used for the treatment of non-small cell lung cancer (NSCLC), locally advanced, unresectable or metastatic pancreatic cancer, and several other types of cancer. It is usually given after other cancer medicines have been tried without success. Erlotinib acts on the epiderm
Table of Content
1 Industry Overview
1.1 Erlotinib Hydrochloride Industry
1.1.1 Overview
1.1.2 Development of Erlotinib Hydrochloride
1.2 Market Segment
1.2.1 By Product Type
1.2.2 By Application
1.3 Asia-Pacific Overview
2 Major Companies List
2.1 Roche (Company Profile, Products & Services, Sales Data etc.)
2.2 Cipla (Company Profile, Products